Medical Military Blogs

Some markers that are detected in the tumor used to decide the best therapeutic

There are no diseases but sick. This statement, valid for any disease, it is even more in the case of cancer. Each tumor behaves differently and, therefore, is necessary to implement personalized treatments tailored to each patient.

The identification of substances expressing tumors, called markers, and the realization of xenografts, animal tissue in humans, are some of the medical advances that have enabled the operation of this Amended cancer medicine.

Differentiated Medicine

“The one size fits all” no longer makes sense. For some time, the word cancer, in fact, encompasses more than 200 diseases. Furthermore, no patients are alike. The medical professionals are aware that a patient does not work the same treatment to another. In the words of Manuel Hidalgo, director of the Comprehensive Cancer Center Clara Campal (Ciocc), “no two tumors are alike, all are different, no diseases, only patients.”

The model “one size fits all” (“everything fits all”) is no longer valid. The smaller group of patients can be selected to adequately treat a disease cancer is one person, according to Hidalgo explained in the “Cycle individualized medicine, health innovation and economic development”, organized by the Foundation and the Roche Institute Bamberg, in collaboration with the Ministry of Education and Science and the Center for Scientific Research (CSIC). The current challenge applied to personalized medicine in oncology is to develop, adopt and use treatments to individual patients.

credit to: CLARA BASSI

Possibility Related Posts:

• Individualized Treatment of Cancer: Prognostic Markers
  In recent years we have discovered some tumor markers (substances found in the body when cancer) that fairly reliably augur tumor progression and prognosis. But not all tumors express the same markers...
• Physical Activity May Reduce the Risk of Cancer
  physical activity Cancer is a disease that kills more people during the year. Its destructive power is very important and does not distinguish nationality, social background or economic status. The W...
• Medicine for Liver Cancer
  The FDA approved the first time in 30 years, an indication of antitumor Nexavar for treating liver cancer. Also, the drug received approval from European authorities. The FDA approval was based o...
• Breast Cancer
  Breast cancer is a major public health problem for women worldwide. In the United States, breast cancer remains the most common cancer in women and the second most common cause of cancer death. In 200...
• The Male Breast Cancer
  Male breast cancer is rare compared with female breast cancer, but if available, about 1% of breast cancers that are diagnosed are male. Because this is usually paid little attention and diagnosed ...